Federated Hermes’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-113
| Closed | -$804 | – | 2254 |
|
2023
Q2 | $804 | Sell |
113
-172
| -60% | -$1.22K | ﹤0.01% | 2035 |
|
2023
Q1 | $2.12K | Buy |
285
+18
| +7% | +$134 | ﹤0.01% | 2000 |
|
2022
Q4 | $1.94K | Buy |
267
+34
| +15% | +$247 | ﹤0.01% | 2005 |
|
2022
Q3 | $2K | Sell |
233
-13,046
| -98% | -$112K | ﹤0.01% | 1997 |
|
2022
Q2 | $254K | Buy |
13,279
+4,121
| +45% | +$78.8K | ﹤0.01% | 1501 |
|
2022
Q1 | $455K | Sell |
9,158
-3,622
| -28% | -$180K | ﹤0.01% | 1477 |
|
2021
Q4 | $965K | Sell |
12,780
-22
| -0.2% | -$1.66K | ﹤0.01% | 1285 |
|
2021
Q3 | $1.01M | Sell |
12,802
-23
| -0.2% | -$1.82K | ﹤0.01% | 1275 |
|
2021
Q2 | $1.78M | Buy |
12,825
+12,808
| +75,341% | +$1.78M | ﹤0.01% | 1131 |
|
2021
Q1 | $4K | Buy |
+17
| New | +$4K | ﹤0.01% | 2085 |
|